JMP Securities analyst Reni Benjamin maintained a Hold rating on Sana Biotechnology (SANA – Research Report) today. The company’s shares opened today at $1.75. Discover outperforming stocks ...

Sana Biotechnology has a 1 year low of $1.52 and a 1 year high of $12.00. Sana Biotechnology ( NASDAQ:SANA – Get Free Report ) last issued its quarterly earnings results on Friday, November 8th.

Sana Biotechnology (SANA) and eBay (EBAY) are two of the stocks rallying this morning despite the market's losses. Sana is soaring nearly 250%, while eBay is climbing a much more modest 12%.

Fintel reports that on January 8, 2025, TD Cowen upgraded their outlook for Sana Biotechnology (NasdaqGS:SANA) from Hold to Buy. Analyst Price Forecast Suggests 518.18% Upside As of December 23 ...

Shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $3.25, but opened at $3.15. Sana Biotechnology ...

Sana Biotechnology (NASDAQ:SANA) climbed over 200% on Wednesday following a sharp rally in the post-market yesterday in reaction to a Phase 1 readout for its UP421 cell therapy, which, according ...

SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other smid-cap stocks. As the name suggests, smid-cap stocks have a valuation ...

Sana Biotechnology, Inc. stock will be surging today after the company showed it can safely administer its allogeneic cell therapy for diabetes to a patient with no immunosuppression. Engineered ...